"Adrenal Gland Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the ADRENAL GLANDS.
Descriptor ID |
D000310
|
MeSH Number(s) |
C04.588.322.078 C19.053.347 C19.344.078
|
Concept/Terms |
Adrenal Gland Neoplasms- Adrenal Gland Neoplasms
- Adrenal Gland Neoplasm
- Neoplasm, Adrenal Gland
- Adrenal Neoplasm
- Adrenal Neoplasms
- Neoplasm, Adrenal
- Neoplasms, Adrenal
- Neoplasms, Adrenal Gland
Adrenal Cancer- Adrenal Cancer
- Adrenal Cancers
- Cancer, Adrenal
- Cancers, Adrenal
- Cancer of the Adrenal Gland
- Adrenal Gland Cancer
- Adrenal Gland Cancers
- Cancer, Adrenal Gland
- Cancers, Adrenal Gland
|
Below are MeSH descriptors whose meaning is more general than "Adrenal Gland Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Adrenal Gland Neoplasms".
This graph shows the total number of publications written about "Adrenal Gland Neoplasms" by people in this website by year, and whether "Adrenal Gland Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 1 | 5 |
1995 | 3 | 1 | 4 |
1996 | 2 | 0 | 2 |
1997 | 2 | 1 | 3 |
1998 | 1 | 2 | 3 |
1999 | 1 | 1 | 2 |
2000 | 3 | 1 | 4 |
2001 | 1 | 0 | 1 |
2002 | 3 | 1 | 4 |
2003 | 4 | 1 | 5 |
2004 | 4 | 2 | 6 |
2005 | 7 | 0 | 7 |
2006 | 5 | 0 | 5 |
2007 | 7 | 0 | 7 |
2008 | 9 | 2 | 11 |
2009 | 7 | 0 | 7 |
2010 | 7 | 3 | 10 |
2011 | 6 | 1 | 7 |
2012 | 8 | 1 | 9 |
2013 | 10 | 1 | 11 |
2014 | 6 | 0 | 6 |
2015 | 7 | 1 | 8 |
2016 | 4 | 1 | 5 |
2017 | 10 | 0 | 10 |
2018 | 12 | 3 | 15 |
2019 | 7 | 0 | 7 |
2020 | 15 | 0 | 15 |
2021 | 9 | 0 | 9 |
2022 | 9 | 0 | 9 |
2023 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenal Gland Neoplasms" by people in Profiles.
-
TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab. 2023 Apr 13; 108(5):1132-1142.
-
Succinate Dehydrogenase Mutations as Familial Pheochromocytoma Syndromes. Surg Oncol Clin N Am. 2023 04; 32(2):289-301.
-
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants. Lancet Diabetes Endocrinol. 2023 May; 11(5):345-361.
-
Proposed MIBG Scan-Based Tumor Response Criteria of High-Specific-Activity 131 I-MIBG Therapy in Metastatic Pheochromocytoma/Paraganglioma. Clin Nucl Med. 2023 Apr 01; 48(4):320-323.
-
Functional Imaging Evidence of Tumor Response to High-Specific-Activity 131 I-MIBG Therapy in an 84-Year-Old Patient With Metastatic Pheochromocytoma/Paraganglioma. Clin Nucl Med. 2023 May 01; 48(5):426-427.
-
Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma. Endocr Relat Cancer. 2023 02 01; 30(2).
-
Lexicon for adrenal terms at CT and MRI: a consensus of the Society of Abdominal Radiology adrenal neoplasm disease-focused panel. Abdom Radiol (NY). 2023 03; 48(3):952-975.
-
The prevalence and spectrum of reported incidental adrenal abnormalities in abdominal computed tomography of cancer patients: The experience of a comprehensive cancer center. Front Endocrinol (Lausanne). 2022; 13:1023220.
-
American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary. JAMA Surg. 2022 10 01; 157(10):870-877.
-
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma. Endocr Relat Cancer. 2022 09 01; 29(9):533-544.